Although breast cancer in vitro and in vivo models were mainly used for analyzing the anti-cancer effects of M1-21 in this study, we believe that M1-21 possesses a broad spectrum inhibiting multiple types of cancer because of its targeting to FOXM1. The gene discussed is FOXM1; the disease is breast carcinoma.